Claim(permalink)
£280 million of taxpayers’ money is going to Lilly to fund the NHS weight loss injection trial.
✓full-fact rating: not verifiable; published on 2024-10-23
Factors
veracity
not verifiable
Political Leaning
right political leaning
Sentiment
neutral sentiment
Date published
2024-10-23
Entities
Eli Lilly and CompanyBiologyPharmaceutical industryObesityWeight lossSocial mediaUnited KingdomSemaglutideFull FactWes Streeting